259 reports of this reaction
1.7% of all CHLORPHENIRAMINE MALEATE reports
#11 most reported adverse reaction
COUGH is the #11 most commonly reported adverse reaction for CHLORPHENIRAMINE MALEATE, manufactured by Rite Aid Corporation. There are 259 FDA adverse event reports linking CHLORPHENIRAMINE MALEATE to COUGH. This represents approximately 1.7% of all 15,638 adverse event reports for this drug.
Patients taking CHLORPHENIRAMINE MALEATE who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
COUGH is a less commonly reported adverse event for CHLORPHENIRAMINE MALEATE, but still significant enough to appear in the safety profile.
In addition to cough, the following adverse reactions have been reported for CHLORPHENIRAMINE MALEATE:
The following drugs have also been linked to cough in FDA adverse event reports:
COUGH has been reported as an adverse event in 259 FDA reports for CHLORPHENIRAMINE MALEATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
COUGH accounts for approximately 1.7% of all adverse event reports for CHLORPHENIRAMINE MALEATE, making it a notable side effect.
If you experience cough while taking CHLORPHENIRAMINE MALEATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.